GEMZAR Safety Questions, GEMZAR Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about GEMZAR. Our extensive database of GEMZAR adverse events and GEMZAR warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about GEMZAR
GEMZAR Safety Reports
Total GEMZAR reports: 649.GEMZAR FDA safety alerts: No.
Reported deaths: 181 Reported hospitalizations: 337.
Take GEMZAR Side Effects Survey or Share Your GEMZAR Story. GEMZAR Usage.
Showing 1-75 of 649 Next >
Physician from GERMANY reported GEMZAR problem on Feb 09, 2007. Female patient, 76 years of age, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased, blood cholinesterase decreased, blood creatinine increased, haemoglobin decreased, malignant neoplasm progression, platelet count decreased, prothrombin time prolonged, transaminases increased. GEMZAR dosage: 1000 MG/M2, UNK. Patient was hospitalized. Patient recovered.GEMZAR problem was reported by a Physician from UNITED STATES on Feb 14, 2007. Male patient, 60 years of age, was diagnosed with bladder cancer stage iv and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, scleroderma, sepsis, thrombocytopenia, vasculitis necrotising. GEMZAR dosage: 2000 MG, OTHER. During the same period patient was treated with CISPLATIN, TAXOL, CARBOPLATIN. Patient died on 02/01/2007.
Physician from UNITED STATES reported GEMZAR problem on Feb 12, 2007. Male patient, 60 years of age, was diagnosed with bladder cancer stage iv and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, scleroderma, sepsis, thrombocytopenia, vasculitis necrotising. GEMZAR dosage: 2000 MG, OTHER. During the same period patient was treated with CISPLATIN. Patient died on 02/01/2007.
GEMZAR problem was reported by a Physician from JAPAN on Feb 14, 2007. Female patient, 77 years of age, weighting 146.6 lb, was diagnosed with lung adenocarcinoma stage iv, hypertension, hyperlipidaemia, cough, asthma, insomnia and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: constipation, deep vein thrombosis, malaise, pulmonary embolism, white blood cell count decreased. GEMZAR dosage: 1000 MG, OTHER. During the same period patient was treated with NAVELBINE, DIOVAN, NORVASC, LIPITOR, MUCODYNE, SINGULAIR, LENDORMIN, HOKUNALIN. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported GEMZAR problem on Feb 14, 2007. Male patient, 75 years of age, was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: diarrhoea haemorrhagic, gastrointestinal necrosis. GEMZAR dosage: unknown. During the same period patient was treated with PACLITAXEL. Patient recovered.
GEMZAR problem was reported by a Physician from AUSTRALIA on Feb 12, 2007. Female patient, 52 years of age, was diagnosed with non-small cell lung cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: dyspnoea, pruritus, rash, swollen tongue. GEMZAR dosage: 2100 MG, OTHER. During the same period patient was treated with CISPLATIN. Patient recovered.
Physician from GERMANY reported GEMZAR problem on Feb 15, 2007. Male patient, 71 years of age, weighting 1649 lb, was diagnosed with bronchial carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, dyspnoea, hyperhidrosis, lung disorder, respiratory failure, tachycardia. GEMZAR dosage: 1853.5 MG, UNK. Patient recovered.
GEMZAR problem was reported by a Physician from JAPAN on Feb 15, 2007. Male patient, 65 years of age, weighting 121.3 lb, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: cholangitis, hepatic function abnormal. GEMZAR dosage: 1500 MG, OTHER. During the same period patient was treated with RUEFRIEN, LANSOPRAZOLE, SENNOSIDE A, MYSLEE, SOLDEM, KYTRIL, PHYSISALZ. Patient was hospitalized. Patient recovered.
Physician from HUNGARY reported GEMZAR problem on Feb 16, 2007. Female patient, 48 years of age, weighting 141.1 lb, was diagnosed with lung neoplasm malignant and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: bronchitis chronic, metastases to central nervous system, nephrolithiasis, thrombophlebitis superficial. GEMZAR dosage: 200 MG, OTHER. During the same period patient was treated with GLYCERIN, CERUCAL, FRAXIPARINE, MEDROL, QUAMATEL, SPIRIVA, TEGRETOL. Patient was hospitalized. Patient recovered.
GEMZAR problem was reported by a Physician from GERMANY on Feb 16, 2007. Female patient, 72 years of age, was diagnosed with bladder cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: lividity, pain in extremity, poor peripheral circulation. GEMZAR dosage: 1650 MG, WEEKLY (1/W). Patient was hospitalized. Patient recovered.
Physician from SWITZERLAND reported GEMZAR problem on Feb 16, 2007. Male patient, 75 years of age, was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, diarrhoea. GEMZAR dosage: unknown. During the same period patient was treated with NAVELBINE, CARBOPLATIN EBEWE, DILZEM, ASPIRIN, COVERSUM, NITRODERM. Patient was hospitalized. Patient recovered.
GEMZAR problem was reported by a Physician from PAKISTAN on Feb 20, 2007. Female patient, 70 years of age, was diagnosed with breast cancer, antiemetic supportive care and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction. GEMZAR dosage: 1200 MG, OTHER. During the same period patient was treated with NAVELBINE, CISPLATIN, TAVEGYL. Patient died on 11/07/2006.
Physician from JAPAN reported GEMZAR problem on Feb 21, 2007. Female patient, 45 years of age, was diagnosed with lung neoplasm malignant and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: anorexia, nausea, parosmia. GEMZAR dosage: 1000 MG/M2, OTHER. During the same period patient was treated with CISPLATIN, CARBOPLATIN. Patient recovered.
GEMZAR problem was reported by a Physician from FRANCE on Feb 21, 2007. Male patient, 63 years of age, weighting 176.4 lb, was diagnosed with adenocarcinoma pancreas, anaemia and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: livedo reticularis, oedema peripheral, skin necrosis, skin ulcer, toxic skin eruption. GEMZAR dosage: 1000 MG/M2, OTHER. During the same period patient was treated with VENOFER, ARANESP. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported GEMZAR problem on Feb 22, 2007. Male patient, 75 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: henoch-schonlein purpura. GEMZAR dosage: 1000 MG/M2, WEEKLY (1/W). Patient was hospitalized. Patient recovered.
GEMZAR problem was reported by a Physician from JAPAN on Feb 22, 2007. Male patient, 63 years of age, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: intestinal perforation. GEMZAR dosage: unknown. Patient died on 02/22/2007.
Health Professional from UNITED STATES reported GEMZAR problem on Feb 28, 2007. Female patient, weighting 145.0 lb, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, malignant neoplasm progression, pancreatic carcinoma. GEMZAR dosage: 1800MG IV D1,8, Q 21D. During the same period patient was treated with ETOPOSIDE, TARCEVA. Patient died on 12/18/2006.
GEMZAR problem was reported by a Physician from HUNGARY on Feb 16, 2007. Female patient, 59 years of age, was diagnosed with lung neoplasm malignant and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: anaemia, asthenia, disease progression, hospitalisation, nausea, pericardial effusion, urticaria. GEMZAR dosage: 2000 MG, UNK. During the same period patient was treated with CISPLATIN, THERAPEUTIC RADIOPHARMACEUTICALS, BETALOC, QUAMATEL, NUTRIDRINK. Patient was hospitalized. Patient recovered.
Physician from GERMANY reported GEMZAR problem on Feb 22, 2007. Female patient, 71 years of age, was diagnosed with bladder cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: anaemia, catheter related complication, catheter related infection, deep vein thrombosis, influenza like illness, leukopenia, peripheral arterial occlusive disease, thrombocytopenia, urological examination abnormal. GEMZAR dosage: 1500 MG, UNK. During the same period patient was treated with CISPLATIN, CARBOPLATIN, OMNISCAN, AMPICILLIN. Patient was hospitalized. Patient recovered.
GEMZAR problem was reported by a Physician from JAPAN on Feb 22, 2007. Male patient, 50 years of age, was diagnosed with bladder cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: hepatic cirrhosis. GEMZAR dosage: unknown. Patient recovered.
Physician from HUNGARY reported GEMZAR problem on Feb 16, 2007. Female patient, 56 years of age, was diagnosed with lung neoplasm malignant and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: bronchitis chronic, dermatitis, gastritis. GEMZAR dosage: unknown. During the same period patient was treated with CISPLATIN, SPIRIVA, SERETIDE. Patient was hospitalized. Patient recovered.
GEMZAR problem was reported by a Physician from GERMANY on Feb 27, 2007. Male patient, 62 years of age, was diagnosed with lung neoplasm malignant and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: peripheral embolism. GEMZAR dosage: 1000 MG/M2, UNK. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.
Physician from GERMANY reported GEMZAR problem on Feb 27, 2007. Female patient, 70 years of age, was diagnosed with bladder cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: convulsion, headache, vasculitis cerebral. GEMZAR dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.
GEMZAR problem was reported by a Physician from JAPAN on Feb 21, 2007. Male patient, 66 years of age, weighting 108.0 lb, was diagnosed with bile duct cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis chronic, platelet count decreased, renal impairment. GEMZAR dosage: 1100 MG, OTHER. Patient was hospitalized and became disabled. Patient recovered.
Physician from FRANCE reported GEMZAR problem on Nov 10, 2006. Male patient, 63 years of age, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: oedema peripheral, skin ulcer. GEMZAR dosage: 1000 MG/M2, OTHER. Patient recovered.
GEMZAR problem was reported by a Physician from JAPAN on Feb 28, 2007. Male patient, 60 years of age, was diagnosed with malignant neoplasm of renal pelvis and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: gastrointestinal disorder, platelet count decreased. GEMZAR dosage: 1000 MG/M2, OTHER. During the same period patient was treated with CISPLATIN. Patient recovered.
Physician from JAPAN reported GEMZAR problem on Feb 26, 2007. Female patient, 73 years of age, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: carcinoembryonic antigen increased, disseminated intravascular coagulation, jaundice cholestatic, malignant neoplasm progression. GEMZAR dosage: 1000 MG/M2, OTHER. During the same period patient was treated with FLUOROURACIL. Patient was hospitalized. Patient died on 01/01/2005.
GEMZAR problem was reported by a Physician from UNITED STATES on Mar 01, 2007. Female patient, 40 years of age, was diagnosed with malignant neoplasm progression and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia recurrent. GEMZAR dosage: unknown. During the same period patient was treated with TARCEVA. Patient died on 12/18/2006.
Physician from GERMANY reported GEMZAR problem on Mar 02, 2007. Female patient, 70 years of age, was diagnosed with bladder cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: convulsion, headache, vasculitis cerebral. GEMZAR dosage: 500 MG, UNK. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.
GEMZAR problem was reported by a Physician from HUNGARY on Mar 01, 2007. Female patient, 56 years of age, was diagnosed with lung neoplasm malignant and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: dermatitis. GEMZAR dosage: unknown. During the same period patient was treated with CISPLATIN, SPIRIVA, SERETIDE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported GEMZAR problem on Mar 06, 2007. Male patient, 63 years of age, weighting 186.0 lb, was diagnosed with bladder cancer stage iv and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis coronary artery, bladder cancer, cardiomegaly, hydrocele, malignant neoplasm progression, pain, splenomegaly. GEMZAR dosage: unknown. During the same period patient was treated with CISPLATIN, TAXOTERE, CARBOPLATIN, VITAMINS NOS, ASPIRIN, NIACIN, XANAX, MARIJUANA. Patient recovered.
GEMZAR problem was reported by a Physician from ITALY on Feb 26, 2007. Female patient, 74 years of age, was diagnosed with breast cancer metastatic and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: asthenia, gastrointestinal toxicity, neutropenia. GEMZAR dosage: 1000 MG/M2, OTHER. During the same period patient was treated with VINORELBINE. Patient recovered.
Physician from FRANCE reported GEMZAR problem on Mar 07, 2007. Male patient, 67 years of age, weighting 154.3 lb, was diagnosed with lung adenocarcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: anaemia, angiodysplasia, gastrointestinal haemorrhage, rectal haemorrhage, thrombocytopenia. GEMZAR dosage: 1824 MG, OTHER. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.
GEMZAR problem was reported by a Physician from FRANCE on Mar 07, 2007. Female patient, 72 years of age, was diagnosed with ovarian cancer metastatic and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: confusional state, headache, petit mal epilepsy, pulmonary embolism. GEMZAR dosage: unknown. During the same period patient was treated with HEPARIN, PROTHIADEN, ALPRAZOLAM. Patient was hospitalized. Patient recovered.
Physician from IRELAND reported GEMZAR problem on Feb 28, 2007. Female patient, 54 years of age, weighting 154.3 lb, was diagnosed with non-small cell lung cancer stage iv, insomnia and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: neutrophil count decreased, platelet count decreased, pulmonary embolism. GEMZAR dosage: 1200 MG/M2, UNK. During the same period patient was treated with CARBOPLATIN, ESOMEPRAZOLE MAGNESIUM, ZOPICLONE, PROPYLTHIOURACIL, MESULID. Patient was hospitalized. Patient recovered.
GEMZAR problem was reported by a Physician from ITALY on Feb 26, 2007. Female patient, 72 years of age, was diagnosed with breast cancer metastatic and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: anaemia, asthenia, nausea, neutropenia. GEMZAR dosage: 1000 MG/M2, OTHER. During the same period patient was treated with VINORELBINE. Patient died.
Physician from ITALY reported GEMZAR problem on Feb 26, 2007. Female patient, 72 years of age, was diagnosed with breast cancer metastatic and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: asthenia, constipation, deafness, thrombocytopenia. GEMZAR dosage: 1000 MG/M2, OTHER. During the same period patient was treated with VINORELBINE. Patient died.
GEMZAR problem was reported by a Physician from ITALY on Feb 26, 2007. Female patient, 76 years of age, was diagnosed with breast cancer metastatic and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: anaemia, thrombocytopenia, transient ischaemic attack. GEMZAR dosage: 1000 MG/M2, OTHER. During the same period patient was treated with VINORELBINE. Patient recovered.
Physician from FRANCE reported GEMZAR problem on Mar 09, 2007. Male patient, 47 years of age, weighting 176.4 lb, was diagnosed with adenocarcinoma pancreas and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: angina pectoris, thrombotic microangiopathy. GEMZAR dosage: unknown. During the same period patient was treated with XELODA, MOPRAL, CREON, ATENOLOL, KARDEGIC. Patient was hospitalized. Patient recovered.
GEMZAR problem was reported by a Physician from UNITED STATES on Mar 09, 2007. Male patient, 65 years of age, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, lung infiltration. GEMZAR dosage: 2090 MG, UNK. During the same period patient was treated with DECADRON. Patient was hospitalized. Patient recovered.
Physician from GREECE reported GEMZAR problem on Mar 07, 2007. Female patient was diagnosed with ovarian cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis. GEMZAR dosage: 1000 MG/M2, OTHER. During the same period patient was treated with CISPLATIN, ONDASETRON, DEXAMETHASONE. Patient recovered.
GEMZAR problem was reported by a Physician from GERMANY on Mar 12, 2007. Female patient, 69 years of age, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased, blood pressure increased, blood urea increased, cholelithiasis, cholestasis, haemolytic anaemia, idiopathic thrombocytopenic purpura. GEMZAR dosage: 1000 MG/M2, UNK. During the same period patient was treated with TORSEMIDE, ANALGESICS. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported GEMZAR problem on Mar 12, 2007. Male patient, 71 years of age, was diagnosed with malignant neoplasm of renal pelvis and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: platelet count increased. GEMZAR dosage: 1200 MG, OTHER. During the same period patient was treated with RANDA. Patient recovered.
GEMZAR problem was reported by a Physician from JAPAN on Mar 14, 2007. Male patient, 83 years of age, was diagnosed with bile duct cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: pneumonia. GEMZAR dosage: 1000 MG/M2, UNK. Patient died on 03/01/2007.
Physician from JAPAN reported GEMZAR problem on Mar 12, 2007. Male patient, 72 years of age, was diagnosed with lung neoplasm malignant and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: cytomegalovirus infection, gastroenteritis staphylococcal, interstitial lung disease, muscle atrophy, muscle fatigue, myopathy steroid, subclavian vein thrombosis. GEMZAR dosage: 1000 MG, OTHER. During the same period patient was treated with CARBOPLATIN, VINORELBINE TARTRATE. Patient died on 05/15/2004.
GEMZAR problem was reported by a Physician from BRAZIL on Mar 08, 2007. Female patient, 65 years of age, was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: pancytopenia, septic shock. GEMZAR dosage: unknown. During the same period patient was treated with TAXOL, KYTRIL, DEXAMETHASONE, ANTAK, DIPHENHYDRAMINE HYDROCHLORIDE. Patient was hospitalized. Patient died on 11/15/2006.
Physician from FRANCE reported GEMZAR problem on Mar 16, 2007. Male patient, 56 years of age, weighting 158.7 lb, was diagnosed with bile duct cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: anaemia, confusional state, fall, jaundice, pyrexia, subdural haemorrhage, thrombocytopenia, white blood cell count increased. GEMZAR dosage: unknown. During the same period patient was treated with LASIX, ZOPHREN, DELURSAN, NEURONTIN. Patient was hospitalized. Patient recovered.
GEMZAR problem was reported by a Physician from FRANCE on Mar 16, 2007. Female patient, 73 years of age, weighting 103.6 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: diarrhoea, hypertension, hypokalaemia, pancytopenia, pyrexia, venous thrombosis, weight decreased. GEMZAR dosage: unknown. Patient was hospitalized. Patient recovered.
Physician from SOUTH AFRICA reported GEMZAR problem on Mar 15, 2007. Male patient, 83 years of age, was diagnosed with pancreatic carcinoma, vomiting and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: dehydration, prescribed overdose, vomiting. GEMZAR dosage: 1900 MG/M2, ON DAY 1+8; 21 DAY CYCLE. During the same period patient was treated with ZAMANON. Patient was hospitalized. Patient recovered.
GEMZAR problem was reported by a Physician from UNITED STATES on Mar 19, 2007. Male patient, 68 years of age, was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: encephalopathy, hypertensive crisis. GEMZAR dosage: 800 MG, UNK. During the same period patient was treated with CISPLATIN, AVASTIN. Patient died.
Consumer or non-health professional from UNITED STATES reported GEMZAR problem on Mar 16, 2007. Male patient, 57 years of age, was diagnosed with leiomyosarcoma metastatic and was treated with GEMZAR. GEMZAR dosage: unknown. Patient died on 12/03/2006.
GEMZAR problem was reported by a Consumer or non-health professional from BRAZIL on Mar 19, 2007. Female patient, 67 years of age, was diagnosed with lung cancer metastatic, lung neoplasm malignant and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: bone cancer metastatic, bone pain, brain cancer metastatic, platelet count decreased, pyrexia, white blood cell count decreased. GEMZAR dosage: unknown. During the same period patient was treated with DEXAMETHASONE, NAUSEDRON. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported GEMZAR problem on Mar 19, 2007. Male patient, weighting 174.0 lb, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: gastric antral vascular ectasia. GEMZAR dosage: 800 MG/M2, UNK. Patient recovered.
GEMZAR problem was reported by a Physician from BRAZIL on Mar 08, 2007. Male patient, 25 years of age, weighting 183.0 lb, was diagnosed with extragonadal primary germ cell cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: epistaxis, thrombocytopenia. GEMZAR dosage: 1000 MG/M2, OTHER. During the same period patient was treated with OXALIPLATIN, KYTRIL, ANTAK, DEXAMETHASONE, MAGNESIUM SULPHATE, GLUCONATO DE CALCIO. Patient was hospitalized. Patient recovered.
Physician from AUSTRALIA reported GEMZAR problem on Mar 21, 2007. Female patient, 59 years of age, was diagnosed with leiomyosarcoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: dyspnoea, pain, rash. GEMZAR dosage: 1200 MG, UNK. During the same period patient was treated with TAXOTERE, DEXAMETHASONE, INDERAL, KEFLEX, DIAFORMIN, DIAMICRON, DEPTRAN. Patient was hospitalized. Patient recovered.
GEMZAR problem was reported by a Physician from UNITED STATES on Mar 19, 2007. Male patient, 68 years of age, was diagnosed with non-small cell lung cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: encephalopathy, hypertensive crisis. GEMZAR dosage: 800 MG, UNK. During the same period patient was treated with CISPLATIN, AVASTIN. Patient was hospitalized. Patient died.
Physician from GERMANY reported GEMZAR problem on Mar 21, 2007. Male patient, 78 years of age, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: pyrexia, renal failure acute, renal tubular necrosis. GEMZAR dosage: 1000 MG/M2, UNK. During the same period patient was treated with PANTOZOL, LEVOTHYROXINE, NORVASC, METOPROLOL SUCCINATE, KAMILLOSAN, CIPROFLOXACIN, MOVICOL, KREON. Patient was hospitalized. Patient recovered.
GEMZAR problem was reported by a Physician from FRANCE on Mar 23, 2007. Male patient, 59 years of age, weighting 119.0 lb, was diagnosed with lung neoplasm malignant, pain and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: renal failure acute. GEMZAR dosage: unknown. During the same period patient was treated with ALIMTA, ZOMETA, SOLUPRED, SKENAN, LYRICA, ACTISKENAN, FORLAX, NEXIUM. Patient was hospitalized. Patient recovered.
Physician from GERMANY reported GEMZAR problem on Mar 23, 2007. Male patient, 78 years of age, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: pneumonia, pyrexia, renal failure acute, renal tubular necrosis, urinary tract infection. GEMZAR dosage: 1000 MG/M2, UNK. During the same period patient was treated with PANTOZOL, LEVOTHYROXINE, NORVASC. Patient was hospitalized. Patient recovered.
GEMZAR problem was reported by a Physician from UNITED STATES on June 27, 2006. Male patient, 80 years of age, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, malignant neoplasm progression. GEMZAR dosage: 1000 MG/M2. Patient died on 05/01/2006.
Health Professional from UNITED STATES reported GEMZAR problem on Apr 24, 2006. Female patient, 77 years of age, weighting 101.4 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: nausea, pyrexia, rash maculo-papular. GEMZAR dosage: 1400 MG, OTHER, INTRAVENOUS. During the same period patient was treated with TESSALON, PALONOSETRON, DECADRON, ATIVAN. Patient recovered.
GEMZAR problem was reported by a Health Professional from UNITED STATES on Apr 07, 2006. Female patient, 58 years of age, was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: myocardial infarction. GEMZAR dosage: 1000 MG/M2. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported GEMZAR problem on Mar 22, 2006. Male patient, 45 years of age, was diagnosed with bladder cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased. GEMZAR dosage: unknown. Patient recovered.
GEMZAR problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 20, 2006. Female patient, 65 years of age, was diagnosed with breast cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: platelet count decreased, rash. GEMZAR dosage: unknown. Patient recovered.
Physician from UNITED STATES reported GEMZAR problem on Feb 20, 2006. Female patient was diagnosed with pancreatic carcinoma metastatic and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: diarrhoea. GEMZAR dosage: unknown. Patient recovered.
GEMZAR problem was reported by a Health Professional from UNITED STATES on Feb 21, 2006. Female patient, 62 years of age, was diagnosed with ovarian cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: abdominal distension, ascites. GEMZAR dosage: 1000 MG/M2, INTRAVENOUS. Patient recovered.
Health Professional from UNITED STATES reported GEMZAR problem on Feb 21, 2006. Female patient was diagnosed with ovarian cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: pneumonitis. GEMZAR dosage: 1000 MG/M2, INTRAVENOUS. Patient recovered.
GEMZAR problem was reported by a Physician from UNITED STATES on Jan 31, 2006. Female patient, 70 years of age, was diagnosed with non-small cell lung cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: anaemia, leukopenia, rash. GEMZAR dosage: 1000 MG/M2, INTRAVENOUS. During the same period patient was treated with TAXOTERE. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported GEMZAR problem on Mar 26, 2007. Male patient, 78 years of age, weighting 202.8 lb, was diagnosed with bladder cancer recurrent, transitional cell carcinoma, hypertension, atrial fibrillation and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, gamma-glutamyltransferase increased, hepatocellular damage, sepsis, urinary tract infection, vascular purpura. GEMZAR dosage: 1000 MG/M2, OTHER. During the same period patient was treated with ELOXATINE, SECTRAL, PREVISCAN. Patient was hospitalized. Patient recovered.
GEMZAR problem was reported by a Physician from FRANCE on Mar 26, 2007. Male patient, 56 years of age, weighting 158.7 lb, was diagnosed with lung neoplasm malignant and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: pancytopenia, pyrexia. GEMZAR dosage: unknown. Patient was hospitalized. Patient recovered.
Physician from reported GEMZAR problem on Mar 28, 2007. Male patient, 59 years of age, weighting 211.6 lb, was diagnosed with non-small cell lung cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: acute pulmonary oedema, dyspnoea, hypertensive crisis, respiratory acidosis. GEMZAR dosage: 1600 MG, UNK. Patient died on 02/03/2007.
GEMZAR problem was reported by a Physician from GERMANY on Mar 28, 2007. Male patient, 60 years of age, weighting 196.2 lb, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, cough, dyspnoea, interstitial lung disease, lung infiltration. GEMZAR dosage: 1000 MG/M2, UNK. Patient recovered.
Physician from BELGIUM reported GEMZAR problem on Mar 29, 2007. Female patient, 69 years of age, was diagnosed with squamous cell carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: radiation pneumonitis. GEMZAR dosage: unknown. Patient was hospitalized and became disabled. Patient died.
GEMZAR problem was reported by a Physician from FRANCE on Mar 27, 2007. Male patient, 56 years of age, weighting 158.7 lb, was diagnosed with bile duct cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: anaemia, confusional state, fall, jaundice, pyrexia, subdural haemorrhage, thrombocytopenia, white blood cell count increased. GEMZAR dosage: 1800 MG, OTHER. During the same period patient was treated with LASIX, ZOPHREN, DELURSAN, NEURONTIN. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported GEMZAR problem on Mar 29, 2007. Female patient, 41 years of age, weighting 145.5 lb, was diagnosed with breast cancer metastatic and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: intestinal ulcer. GEMZAR dosage: unknown. During the same period patient was treated with TAXOL, AVASTIN. Patient was hospitalized. Patient recovered.
Showing 1-75 of 649 Next >
This
drug has an active FDA Safety Alert